Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Atea Pharmaceuticals (AVIR) Total Non-Current Liabilities (2020 - 2022)

Historic Total Non-Current Liabilities for Atea Pharmaceuticals (AVIR) over the last 3 years, with Q3 2022 value amounting to $18.2 million.

  • Atea Pharmaceuticals' Total Non-Current Liabilities changed N/A to $18.2 million in Q3 2022 from the same period last year, while for Sep 2022 it was $18.2 million, marking a year-over-year change of. This contributed to the annual value of $56.9 million for FY2021, which is 8198.74% down from last year.
  • According to the latest figures from Q3 2022, Atea Pharmaceuticals' Total Non-Current Liabilities is $18.2 million.
  • In the past 5 years, Atea Pharmaceuticals' Total Non-Current Liabilities registered a high of $315.8 million during Q4 2020, and its lowest value of $10.8 million during Q3 2020.
  • For the 3-year period, Atea Pharmaceuticals' Total Non-Current Liabilities averaged around $123.6 million, with its median value being $44.1 million (2021).
  • In the last 5 years, Atea Pharmaceuticals' Total Non-Current Liabilities tumbled by 8198.74% in 2021 and then tumbled by 8981.45% in 2022.
  • Quarter analysis of 3 years shows Atea Pharmaceuticals' Total Non-Current Liabilities stood at $315.8 million in 2020, then tumbled by 81.99% to $56.9 million in 2021, then plummeted by 67.97% to $18.2 million in 2022.
  • Its last three reported values are $18.2 million in Q3 2022, $27.9 million for Q2 2022, and $31.4 million during Q1 2022.